Moguel-Ancheita R, Moguel-Ancheyta B

Idioma: Inglés [English version]
Referencias bibliográficas: 14
Paginas: 82-84
Archivo PDF: 113.59 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. American Psychological Association. Understanding transgender people, gender identity and gender expression. 2023. AVAilable in: https://www.apa.org/topics/lgbtq/transgender-people-gender-identity-gender-expression

2. Instituto Nacional de Estadística y Geografía. Comunicado de prensa número 340/22. Encuesta nacional sobre diversidad sexual y de género (ENDISEG) 2021. 2022. Disponible en: www.inegi.org.mx/contenidos/saladeprensa/boletines/2022/endiseg/Resul_Endiseg21.pdf

3. Esquina 32. Comunidad transgénero es cinco veces más propensa a un infarto al miocardio. Tijuana BC: 2022. Disponible en: https://esquina32.info/2022/09/comunidad-transgenero-es-cinco-veces-mas-propensa-a-un-infarto-al-miocardio/

4. Alzahrani T, Nguyen T, Ryan A, Dwairy A, McCaffrey J, Yunus R et al. Cardiovascular disease risk factors and myocardial infarction in the transgender population. Circ Cardiovasc Qual Outcomes. 2019; 12 (4): e005597.

5. Moguel-Ancheita R, Arce-Piña L, Lozoya-Morales JJ, Ramos-Cházaro E, Cuevas-Cueto D, Lozoya-del-Rosal JJ et al. Mexican Consensus of Chronic Ischemic Heart Disease. Non-invasive diagnosis, classification, and stratification. Mexican College of Interventional Cardiology and Endovascular Therapy (COMECITE). Cardiovasc Metab Sci. 2021; 32 (s4): s288-s316.

6. Muka T, Oliver-Williams C, Kunutsor S, Laven JS, Fauser BC, Chowdhury R et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA Cardiol. 2016; 1 (7): 767-776.

7. Chan Swe N, Ahmed S, Eid M, Poretsky L, Gianos E, Cusano NE. The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review. Metabol Open. 2022; 13: 100173.

8. Ramsay A, Safer JD. Update in adult transgender medicine. Annu Rev Med. 2023; 74: 117-124. doi: 10.1146/annurev-med-020222-121106.

9. Streed CG Jr, Beach LB, Caceres BA, Dowshen NL, Moreau KL, Mukherjee M et al. Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association. Circulation. 2021; 144 (6): e136-e148. Erratum in: Circulation. 2021; 144 (6): e150.

10. Abeyratne D, Ratnayake GM, Wijetnga UA, Wijenayake U, BUlugahapitiya US. Review on the transgender literature: where are we now and a step beyond the current practice? Endocrines. 2022, 3 (2): 317-328.

11. Seal LJ. Cardiovascular disease in transgendered people: A review of the literature and discussion of risk. JRSM Cardiovasc Dis. 2019; 8: 2048004019880745.

12. Pellicane MJ, Ciesla JA. Associations between minority stress, depression, and suicidal ideation and attempts in transgender and gender diverse (TGD) individuals: Systematic review and meta-analysis. Clin Psychol Rev. 2022; 91: 102113. doi: 10.1016/j.cpr.2021.102113.

13. Seelman KL, Colón-Diaz MJP, LeCroix RH, Xavier-Brier M, Kattari L. Transgender noninclusive healthcare and delaying care because of fear: connections to general health and mental health among transgender adults. Transgend Health. 2017; 2 (1): 17-28. doi: 10.1089/trgh.2016.0024.

14. Diario Oficial de la Federación. SEGOB. 21/12/2021. Acción de inconstitucionalidad 54/2018. Disponible en: https://dof.gob.mx/nota_detalle.php?codigo=5638915&fecha=21/12/2021#gsc.tab=0